MiR-378 amplified osteoarthritis (OA) development via repressing chondrocyte autophagy and by inhibiting bone marrow MSC chondrogenesis, thus indicating miR-378 may be a potential therapeutic target for OA treatments.
[Molecular Therapy-Nucleic Acids]